Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-13 Sale |
2023-02-15 4:30 pm |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
2,790 | $9.6653 | $26,966 | 65,559 (Direct) |
View |
| 2022-06-15 Sale |
2022-06-16 4:15 pm |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
5,145 | $10.06 | $51,745 | 68,349 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-10 Option Award |
2022-02-11 4:21 pm |
N/A 2032-02-09 |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
125,107 | $0 | 166,892 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-23 4:10 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
9,084 | $0 | 41,785 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 4:19 pm |
N/A 2031-06-13 |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
85,419 | $0 | 85,419 (Direct) |
View |
Ownership |
2021-06-16 4:18 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-08-15 Tax Withholding |
2020-08-18 6:15 pm |
N/A N/A |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Shearman Mark S Chief Scientific Officer |
5,723 | $5.77 | 33,277 (Direct) |
View |
| 2020-08-05 Option Award |
2020-08-07 8:07 pm |
N/A 2030-08-05 |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Shearman Mark S Chief Scientific Officer |
50,000 | $0 | 50,000 (Direct) |
View |